| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $357.5M | +0.4% |
| Cost of Revenue | $212.8M | +1.9% |
| R&D Expense | $30.2M | -8.7% |
| SG&A Expense | $47.6M | -0.2% |
| Operating Income | $4.5M | +107.6% |
| Pre-tax Income | -$8.1M | +86.4% |
| Income Tax | $1.9M | +108.7% |
| Net Income | -$10.0M | +83.4% |
| EPS (Basic) | $4.30 | +127.7% |
| EPS (Diluted) | $4.25 | +127.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.6M | -21.1% |
| Accounts Receivable | $57.3M | -10.9% |
| Current Assets | $96.3M | -10.9% |
| Total Assets | $407.7M | -5.2% |
| Current Liabilities | $122.9M | -6.4% |
| Long-term Debt | $41.5M | +0.9% |
| Total Liabilities | $206.5M | -10.6% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $22.7M | +25.6% |
| Capital Expenditures | $956K | +17.6% |
| Investing Cash Flow | -$23.4M | +2.8% |
| Financing Cash Flow | -$7.0M | -139.7% |
| Free Cash Flow | $21.8M | +26.0% |
| $111.4M |
| +1448.7% |